Literature DB >> 19414142

Hereditary gastric cancer.

Carla Oliveira1, Raquel Seruca, Fátima Carneiro.   

Abstract

Gastric cancer is a heterogeneous and highly prevalent disease, being the fourth most common cancer and the second leading cause of cancer associated death worldwide. Most cases are sporadic and familial clustering is observed in about 10% of the cases. Hereditary gastric cancer accounts for a very low percentage of cases (1-3%) and a single hereditary syndrome - Hereditary Diffuse Gastric Cancer (HDGC) - has been characterised. Among families that fulfil the clinical criteria for HDGC, about 40% carry CDH1 germline mutations, the genetic cause of the others being unknown. The management options for CDH1 asymptomatic germline carriers are intensive endoscopic surveillance and prophylactic gastrectomy. In this chapter we review the pathophysiology and clinicopathological features of HDGC and discuss issues related with genetic testing and management of family members.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414142     DOI: 10.1016/j.bpg.2009.02.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  26 in total

Review 1.  Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.

Authors:  Shelby D Melton; Robert M Genta; Rhonda F Souza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

Review 2.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

3.  Familial gastric cancer: update for practice management.

Authors:  Giovanni Corso; Daniele Marrelli; Franco Roviello
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  [Pseudoneoplastic regeneration of the stomach. Histopathology and differential diagnosis].

Authors:  M Vieth; D Görgens; C Langner
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

Review 5.  Resolving gastric cancer aetiology: an update in genetic predisposition.

Authors:  Paul C Lott; Luis G Carvajal-Carmona
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-12

6.  Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients.

Authors:  Karolina Zuk; Lukasz Peczek; Krystyna Stec-Michalska; Marta Medrek; Barbara Nawrot
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

7.  Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC).

Authors:  Carla Oliveira; Raquel Seruca; Nicoline Hoogerbrugge; Marjolijn Ligtenberg; Fátima Carneiro
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 8.  Surveillance for gastrointestinal malignancies.

Authors:  Ashish K Tiwari; Heather S Laird-Fick; Ramesh K Wali; Hemant K Roy
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

9.  Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA.

Authors:  Renata Bordeira-Carriço; Daniel Ferreira; Denisa D Mateus; Hugo Pinheiro; Ana Paula Pêgo; Manuel A S Santos; Carla Oliveira
Journal:  Eur J Hum Genet       Date:  2014-01-15       Impact factor: 4.246

10.  Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.

Authors:  Michael D Black; Raynette Kaneshiro; Jennifer I Lai; David M Shimizu
Journal:  Hawaii J Med Public Health       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.